Searched for
SYMBIOTEC PHARMALAB SHARE PRICE
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 1...- These 7 bank stocks have an upside potential of up to 27% in one year, according to analystsConsider how things have panned out for the banking sector in Q1 FY27. The quality of loan books has improved. Though credit growth was not...
- Two Trades for Today: A private sector defence firm for a 7.65% upmove, a mid-cap capital goods stock for an almost 6% gainOur technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- For investors with ability to ignore short-term volatility: 5 mid-cap stocks from different sectors with upside potential up to 19%Most of what impacts the market these days comes from outside the country: Oil price spikes, tariff threats, FII pull out. There is, howeve...
- Milky Mist shares hit 10% upper circuit after market debut, rally 30% from IPO price. Should you buy, sell or hold?Milky Mist Dairy Food shares surged 10 per cent to hit the upper circuit at Rs 181.50 post-debut, marking a 30 per cent gain over its issue...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Market breadth is important, especially at this point of time. It is a better indicator of both underlying sentiment and what is likely in ...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 23%There are currently too many variables that can move the markets in either direction. Oil prices may have settled into a range for now, but...
- Top Nifty50 stocks analysts suggest buying in this volatile weekStock Reports Plus, powered by Refinitiv, is a comprehensive report that evaluates five key components of 4,000+ listed stocks – earnings, ...
- Chemical sector: Although long, there is a way around China trouble; combine 20 stocks to get your portfolio’s chemistry rightFor the chemicals sector, it all depends on a transformation that is still unfolding and will take years to play out. Backward-integration ...
- NMDC shares decline 4% after Q1 results. Should you buy, sell or hold the stock?NMDC shares fell 4% despite a 2% YoY rise in Q1FY27 profit to Rs 2,007 crore, while revenue increased 2% to Rs 6,795 crore. Iron ore produc...
- Real estate stocks: Time for a tactical relocation? 10 stocks with an upside potential of up to 35%In its operating matrix, the real estate sector is different from most sectors listed on the exchanges. In fact, a large part of the indust...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%It is good to set expectations from the market. It helps reduce volatility-related anxiety. For now, ignore what is happening to the Nifty ...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsLooking at what happens in the short term is important, as it does have an impact on stock prices. But also always keep an eye on the macro...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 23%Market breadth (always a better indicator of the underlying sentiment) has remained positive for a few trading sessions in a row. This is w...
- Aarti Pharmalabs shares rally over 33% in two days post Q1 results. What is driving the surge?Aarti Pharmalabs shares have surged 33% in two days after the company reported a 65.4% year-on-year rise in Q1FY27 profit and 38.7% growth ...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- Aarti Pharmalabs shares hit 20% upper circuit as Q1 net profit surges 65% YoY to Rs 76 croreAarti Pharmalabs shares hit the 20% upper circuit after the company reported a 65.4% year-on-year rise in Q1 FY27 net profit to Rs 76.14 cr...
- Defence stocks: Time to change strategy? 18 stocks with downside and upside potential from minus 26% to plus 26%When a stock remains in the red for several months, investors naturally begin questioning the investment. Imagine a shipbuilder remaining w...
Load More
